MedTrace Logo

Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)

NCT00740025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2010-10-14

No results posted yet for this study

Summary

This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.

Conditions

  • Pregnancy

Sponsors & Collaborators

  • Virginia Center for Reproductive Medicine

    lead OTHER

Principal Investigators

  • Fady I Sharara, M.D · Virginia Center for Reproductive Medicine

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00740025 on ClinicalTrials.gov